Addiction Medicine

Neurobiological Mechanisms of Opioid Dependence

Investigation of molecular and cellular pathways underlying opioid addiction through receptor pharmacology and synaptic plasticity studies.

RESEARCH GAP FRONTIERS

Genetic Polymorphisms in Addiction Susceptibility

Examination of specific genetic variants and their role in determining individual vulnerability to substance use disorders.

RESEARCH GAP FRONTIERS

Epigenetic Modifications in Chronic Drug Use

Study of DNA methylation and histone modifications as mechanisms underlying long-term addiction and relapse vulnerability.

RESEARCH GAP FRONTIERS

Prefrontal Cortex Dysfunction in Addiction

Research on impaired executive function and decision-making processes resulting from substance-induced neurobiological changes.

RESEARCH GAP FRONTIERS

Reward System Sensitization and Tolerance

Investigation of dopaminergic pathway adaptations leading to altered reward processing and escalating drug consumption.

RESEARCH GAP FRONTIERS

Stress-Induced Relapse Mechanisms

Examination of hypothalamic-pituitary-adrenal axis dysfunction and its contribution to craving and relapse vulnerability.

RESEARCH GAP FRONTIERS

Adolescent Brain Development and Substance Vulnerability

Study of developmental neurobiological factors increasing susceptibility to addiction during critical periods of maturation.

RESEARCH GAP FRONTIERS

Medication-Assisted Treatment Optimization

Research on enhanced protocols and dosing strategies for opioid agonist and antagonist therapies in addiction management.

RESEARCH GAP FRONTIERS

Buprenorphine Pharmacodynamics and Clinical Application

Investigation of partial mu-opioid agonist mechanisms and treatment outcomes across diverse patient populations.

Naltrexone Extended-Release Formulations

Development and evaluation of long-acting opioid antagonist therapies for improved medication adherence and outcomes.

Psychosocial Interventions for Co-occurring Disorders

Research on integrated cognitive-behavioral and motivational enhancement therapies for addiction with psychiatric comorbidities.

Community Reinforcement Approach Efficacy

Investigation of behavioral economic principles in restructuring environmental contingencies to support recovery.

Contingency Management and Incentive Programs

Study of operant conditioning-based interventions using tangible reinforcements for sustained abstinence and treatment engagement.

Fentanyl-Specific Addiction Neurobiology

Research on unique pharmacological and neurobiological features of synthetic opioid dependence and overdose mechanisms.

Methamphetamine-Induced Neurotoxicity

Investigation of dopaminergic and glutamatergic system damage from stimulant abuse and potential neuroprotective interventions.

Alcohol-Related Neuroinflammation and Neurodegeneration

Study of microglial activation and neuroinflammatory cascades contributing to alcohol use disorder pathology.

Cannabis Cannabinoid Receptor Dysregulation

Examination of endocannabinoid system dysfunction and its role in cannabis use disorder development and persistence.

Benzodiazepine Dependence and Withdrawal Syndrome

Research on GABA-A receptor adaptation mechanisms and evidence-based tapering protocols for benzodiazepine cessation.

Polysubstance Use and Drug Interaction Effects

Investigation of combined neurotoxic effects and treatment complexities in individuals using multiple substance classes.

Sex Differences in Addiction Vulnerability

Research on hormonal and neurobiological factors explaining differential addiction trajectories between males and females.

Trauma-Informed Addiction Treatment Models

Study of therapeutic approaches addressing post-traumatic stress and childhood adverse experiences in addiction recovery.

Neuroimaging Biomarkers for Treatment Response

Development of functional MRI and PET imaging markers predicting individual response to addiction pharmacotherapies.

Biomarker Discovery for Addiction Phenotyping

Research on biological and behavioral markers enabling precision medicine approaches in addiction treatment selection.

Circadian Rhythm Disruption in Addiction

Investigation of sleep-wake cycle abnormalities and chronobiological interventions in substance use disorder management.

Microbiome-Gut-Brain Axis in Addiction

Study of dysbiosis-related neuroinflammation and potential probiotic interventions in addiction pathophysiology.

Immunotherapy Approaches for Addiction

Research on immunization and passive immunization strategies targeting drug metabolites and blocking rewarding effects.

Deep Brain Stimulation for Addiction Treatment

Investigation of neuromodulation targeting reward circuits and prefrontal regions in treatment-resistant addiction.

Transcranial Magnetic Stimulation for Craving Reduction

Research on non-invasive brain stimulation protocols targeting cue-induced craving and executive dysfunction.

Virtual Reality Exposure Therapy for Addiction

Study of immersive VR environments for cue exposure and relapse prevention in addiction treatment.

Artificial Intelligence in Addiction Risk Prediction

Development of machine learning algorithms predicting relapse risk and optimizing personalized intervention timing.

Mobile Health Technologies for Recovery Support

Research on smartphone applications and wearable devices enabling remote monitoring and just-in-time interventions.

Telemedicine-Delivered Addiction Treatment Models

Investigation of synchronous and asynchronous telehealth platforms for medication management and counseling delivery.

Peer Recovery Support Networks and Efficacy

Study of peer specialist programs and mutual support groups as adjunctive recovery enhancement strategies.

Opioid Overdose Prevention and Reversal Strategies

Research on naloxone distribution programs, overdose education, and enhanced formulations for emergency management.

Drug Checking and Harm Reduction Effectiveness

Investigation of substance analysis services and their impact on overdose prevention and treatment engagement.

Supervised Consumption Facilities and Outcomes

Research on sanctioned consumption settings reducing overdose deaths and improving linkage to treatment services.

Syringe Service Programs and Disease Prevention

Study of needle exchange effectiveness in reducing blood-borne infection transmission and treatment engagement.

Addiction Severity Index and Assessment Refinement

Development of enhanced diagnostic and severity measurement instruments for treatment planning and outcome tracking.

Recovery Capital and Social Determinants of Health

Research on socioeconomic, environmental, and social factors influencing treatment access and long-term recovery outcomes.

Criminal Justice Diversion and Drug Courts

Investigation of coerced treatment effectiveness and recidivism reduction through alternative legal processing pathways.

Medication in Correctional Settings

Research on incarceration-based MAT delivery and continuity of care during community reentry transitions.

Workplace Addiction Prevention and Employee Assistance

Study of occupational health interventions, drug testing policies, and rehabilitation program effectiveness.

Adolescent-Specific Addiction Treatment Interventions

Research on developmentally appropriate therapies addressing unique needs of youth with substance use disorders.

Geriatric Addiction and Aging-Related Considerations

Investigation of substance use in older adults including polypharmacy interactions and age-appropriate interventions.

Prenatal Substance Exposure and Neonatal Outcomes

Study of in utero drug effects on fetal development and evidence-based management of neonatal abstinence syndrome.

Parenting and Family Dynamics in Recovery

Research on family-based interventions addressing parental substance use and child welfare outcomes.

Substance Use and Infectious Disease Comorbidity

Investigation of HIV and hepatitis C acquisition prevention and treatment integration in addiction populations.

Chronic Pain and Opioid Use Disorder Management

Research on balancing pain management and addiction treatment in individuals with concurrent conditions.

Behavioral Addictions and Process Addiction Neurobiology

Study of gambling, gaming, and internet addiction as behavioral conditions with similar neurobiological substrates.

Pharmaceutical Opioid Misuse Epidemiology and Prevention

Research on prescription opioid diversion patterns and evidence-based policies reducing iatrogenic addiction.

Glutamatergic System Dysregulation in Addiction

Investigation of altered glutamate neurotransmission and NMDA receptor function as core mechanisms underlying addictive behavior and withdrawal symptoms across substance classes.

Dopamine Transporter Availability and Relapse Risk

Examination of dopamine transporter density using positron emission tomography as a predictive biomarker for relapse vulnerability and treatment response variability.

Opioid-Induced Hyperalgesia and Pain Sensitization

Study of paradoxical pain amplification mechanisms resulting from chronic opioid exposure and implications for pain management in addiction populations.

Kappa Opioid Receptor Signaling and Dysphoria

Investigation of kappa receptor-mediated negative affect and stress responses as targets for novel anti-addiction pharmacotherapies.

Mu Opioid Receptor Trafficking and Tolerance Development

Analysis of receptor internalization, phosphorylation patterns, and desensitization mechanisms contributing to opioid tolerance and dose escalation.

Neuropeptide Y Dysregulation in Addiction and Recovery

Exploration of altered neuropeptide Y signaling in stress resilience and its therapeutic potential for preventing stress-induced relapse.

Corticotropin-Releasing Factor Signaling in Withdrawal

Investigation of CRF system hyperactivation during withdrawal states and as a therapeutic target for alleviating negative emotional symptoms.

Histone Acetylation and Chromatin Remodeling in Addiction

Study of epigenetic modifications of histone proteins and their role in transcriptional changes underlying addiction memory consolidation.

DNA Methylation Patterns in Addiction Vulnerability

Characterization of cytosine methylation signatures associated with individual differences in addiction susceptibility and recovery potential.

MicroRNA Expression Profiling in Addiction States

Identification and functional validation of altered microRNA expression patterns regulating gene expression in addiction-relevant brain regions.

Anterior Cingulate Cortex Hyperactivity and Craving

Investigation of anterior cingulate overactivity during cue exposure and its relationship to craving intensity and relapse prediction.

Insula Interoception and Craving Phenomenology

Examination of insular cortex function in bodily awareness and its contribution to the subjective experience and expression of addiction cravings.

Amygdala-Prefrontal Connectivity in Fear Extinction

Study of altered communication between amygdala and prefrontal regions affecting extinction learning and cue reactivity in addiction.

Ventral Tegmental Area Neuroplasticity and Sensitization

Analysis of structural and functional changes in VTA dopamine neurons mediating incentive salience and compulsive drug seeking behaviors.

Nucleus Accumbens Core-Shell Dichotomy in Addiction

Differentiation of distinct roles for nucleus accumbens core and shell subregions in drug wanting versus liking and compulsive behavior.

Lateral Habenula Function in Aversion and Relapse

Investigation of lateral habenula-mediated aversive processing and anti-reward signaling as mechanisms underlying relapse propensity.

White Matter Integrity and Cognitive Control in Addiction

Examination of altered white matter organization and fiber tract integrity affecting executive function and impulse control in substance use disorder.

Positron Emission Tomography Receptor Occupancy Studies

Quantification of medication binding to central receptors and optimization of dosing regimens for addiction pharmacotherapies.

Functional Magnetic Resonance Imaging Resting State Networks

Analysis of spontaneous brain activity patterns and network connectivity alterations in addiction and recovery states.

Diffusion Tensor Imaging and Addiction Severity Correlation

Assessment of white matter microstructural changes as quantitative biomarkers of addiction severity and treatment prognosis.

Electroencephalography and Addiction Reward Processing

Use of event-related potentials to characterize altered neural responses to reward-related stimuli in addiction populations.

Alcohol Use Disorder and Thiamine Deficiency Syndromes

Investigation of Wernicke-Korsakoff syndrome pathogenesis and prevention strategies in severe alcohol use disorder.

Stimulant-Induced Cardiomyopathy and Cardiotoxicity

Study of mechanisms underlying cocaine and methamphetamine-induced cardiac dysfunction and long-term cardiovascular consequences.

Hepatitis C and Human Immunodeficiency Virus Coinfection

Management strategies for simultaneous treatment of viral infections and substance use disorder with consideration of medication interactions.

Substance Use and Tuberculosis Comorbidity Outcomes

Examination of treatment adherence challenges and clinical outcomes in individuals with concurrent tuberculosis and addiction.

Immunosuppression and Infection Risk in Addiction

Investigation of immune system dysregulation and increased infection susceptibility as consequences of chronic substance use.

Addiction and Severe Mental Illness Treatment Integration

Development and evaluation of integrated treatment models for individuals with concurrent schizophrenia, bipolar disorder, and substance use.

Anxiety Disorders and Substance Use Disorder Mechanisms

Investigation of shared and distinct neurobiological pathways underlying anxiety-driven self-medication and addiction development.

Major Depressive Disorder and Addiction Phenotypes

Characterization of distinct subtypes of depression-addiction comorbidity and differential treatment response profiles.

Attention-Deficit Hyperactivity Disorder and Addiction Risk

Exploration of executive function deficits and impulse control problems as shared mechanisms increasing addiction vulnerability in ADHD.

Post-Traumatic Stress Disorder and Addiction Etiology

Study of trauma-related dysregulation of fear extinction and negative affect as drivers of substance use in trauma survivors.

Personality Disorder Traits and Treatment Outcome Prediction

Investigation of how personality pathology affects addiction treatment response and recovery trajectory.

Eating Disorders and Substance Use Disorder Overlap

Examination of shared genetic, neurobiological, and psychological mechanisms underlying disordered eating and addiction comorbidity.

Gambling Disorder and Behavioral Addiction Neurobiologyintegration

Investigation of overlapping reward system abnormalities and treatment approaches applicable across behavioral and substance addictions.

Internet Gaming Disorder and Technology Addiction Mechanisms

Study of behavioral addiction to digital technologies and potential neurobiological similarities to substance use disorders.

Social Media Addiction and Adolescent Vulnerability

Investigation of compulsive social media use patterns in adolescents and underlying developmental neurobiology.

Cannabis Potency and Cannabidiol Therapeutic Potential

Examination of increasing THC concentrations in cannabis products and evaluation of CBD as treatment for cannabis use disorder.

Novel Psychoactive Substances Epidemiology and Toxicology

Characterization of emerging designer drugs, their pharmacological properties, and public health surveillance strategies.

Synthetic Opioid Analogs and Potency Variation

Study of ultra-potent synthetic opioids beyond fentanyl and implications for overdose prevention and emergency management.

Polydrug Interactions and Pharmacokinetic Complexity

Investigation of drug-drug interactions and altered metabolism in polysubstance users affecting treatment safety and efficacy.

Acamprosate Mechanism of Action in Alcohol Abstinence

Elucidation of acamprosate-mediated glutamate system restoration and its contribution to maintaining alcohol abstinence.

Disulfiram Metabolism and Efficacy Determinants

Investigation of disulfiram pharmacokinetics and genetic factors affecting its aversive conditioning effects in alcohol use disorder.

Topiramate and Off-Label Addiction Treatment Mechanisms

Examination of topiramate effects on glutamate and GABA neurotransmission relevant to multiple substance use disorders.

Psychedelic-Assisted Therapy for Addiction Recovery

Investigation of psilocybin and MDMA-assisted psychotherapy outcomes for addiction treatment and underlying neurobiological mechanisms.

Cognitive Remediation Training in Addiction Recovery

Development and evaluation of targeted cognitive training interventions addressing executive function deficits in addiction.

Motivational Interviewing Effectiveness and Biomarkers

Identification of neural and behavioral predictors of response to motivational interviewing in addiction treatment.

Cognitive-Behavioral Therapy for Relapse Prevention

Optimization and dissemination of CBT techniques targeting coping skills and high-risk situation management in addiction.

Dialectical Behavior Therapy for Dual Diagnosis

Adaptation and evaluation of DBT for individuals with concurrent addiction and emotion dysregulation disorders.

Acceptance and Commitment Therapy in Addiction Treatment

Investigation of ACT effectiveness in promoting values-based living and psychological flexibility in recovery from addiction.

Twelve-Step Facilitation and Neurobiology of Spirituality

Examination of neural mechanisms underlying spiritual experiences in twelve-step programs and recovery outcomes.

Glutamatergic System Dysfunction in Addiction

Investigation of altered glutamate neurotransmission and NMDA receptor signaling in the development and maintenance of substance use disorders.

Dopamine Transporter Imaging and Disease Progression

Use of PET and SPECT imaging to quantify dopamine transporter availability as a biomarker for addiction severity and treatment outcomes.

Kappa Opioid Receptor Antagonists Development

Design and pharmacological evaluation of novel kappa receptor antagonists for reducing dysphoria and stress-induced relapse vulnerability.

GABA-Ergic Signaling and Withdrawal Severity

Characterization of GABAergic circuit abnormalities underlying acute and protracted withdrawal syndromes across substance classes.

Chronic Inflammation and Addiction Trajectories

Examination of pro-inflammatory cytokine elevation and neuroinflammatory cascades as drivers of addiction persistence and treatment resistance.

Amygdala-Hippocampal Connectivity in Craving

Functional connectivity analysis of emotional memory circuits underlying cue-induced craving and context-dependent relapse.

Methyl-CpG-Binding Protein Modifications in Addiction

Study of MeCP2 and related epigenetic readers in regulating gene expression patterns during addiction development and recovery.

Incentive Salience Attribution and Drug-Seeking

Investigation of how substance-related cues acquire excessive motivational value through aberrant mesolimbic dopamine sensitization.

Binge Drinking Neurotoxicity and Cognitive Outcomes

Assessment of episodic heavy alcohol exposure effects on white matter integrity and executive function across age groups.

Synthetic Cathinone Pharmacology and Addiction Potential

Characterization of bath salt compounds'' neurobiological mechanisms and comparative addiction liability relative to established stimulants.

Nicotine and Cognitive Enhancement Misuse Patterns

Examination of non-smokers'' use of nicotine products for cognitive enhancement and transition to addiction behaviors.

Acetylcholine and Attentional Bias to Drug Cues

Analysis of cholinergic signaling in prefrontal and parietal cortices mediating selective attention to substance-related stimuli.

Anandamide Signaling and Anxiety Regulation

Study of endogenous cannabinoid system''s role in stress buffering and its dysregulation in addiction-anxiety comorbidity.

Stimulant-Induced Psychosis Neurobiology and Treatment

Investigation of dopaminergic overdrive mechanisms in methamphetamine and cocaine-related psychotic symptoms and antipsychotic efficacy.

Orexin Neuropeptide System and Addiction Relapse

Examination of lateral hypothalamic orexin neurons'' role in arousal, motivation, and vulnerability to relapse.

Substance P and Tachykinin Receptor Modulation

Investigation of neurokinin receptor antagonists as therapeutic targets for reducing addiction-related affective disturbances.

Protease-Activated Receptor Signaling in Addiction

Study of PAR1 and PAR4 involvement in neuroinflammation and blood-brain barrier dysfunction during substance use.

Cannabinoid Hyperemesis Syndrome Pathophysiology

Elucidation of mechanisms underlying paradoxical cannabinoid-induced severe vomiting and potential therapeutic interventions.

Inhalant Neurotoxicity and Organic Brain Damage

Long-term follow-up studies characterizing structural brain abnormalities and neuropsychological deficits from volatile substance abuse.

Psychedelic-Assisted Psychotherapy for Addiction

Clinical trials and mechanistic studies of psilocybin and MDMA-augmented therapy for treatment-resistant addiction and craving.

Genetic Variation in Alcohol Metabolism and Risk

Investigation of ADH and ALDH polymorphisms'' protective and risk effects in diverse populations with alcohol use disorder.

Prenatal Alcohol Exposure Epigenetic Programming

Study of transgenerational epigenetic changes and altered addiction vulnerability following in utero alcohol exposure.

Inflammatory Biomarkers in Dual Diagnosis Treatment

Use of IL-6, TNF-alpha, and CRP levels to predict treatment response in addiction-mental illness comorbidity.

Hypoxia-Inducible Factor Pathway in Addiction

Investigation of HIF-1 signaling in chronic hypoxia from substance use and its role in neuroadaptation.

Excitatory-Inhibitory Balance Restoration Strategies

Development of interventions targeting E-I imbalance in addiction through modulation of glutamate, GABA, and neuromodulatory systems.

Cocaine-Induced Cardiovascular Toxicity Mechanisms

Study of cocaine''s direct cardiac effects, arrhythmias, and myocardial infarction risk in addiction populations.

Sleep Architecture Disruption and Addiction Severity

Polysomnographic assessment of sleep stage abnormalities and their relationship to craving intensity and relapse risk.

Neuropeptide Y Enhancement for Anxiety Reduction

Study of NPY delivery strategies and Y2 receptor modulation for stress resilience in addiction treatment.

Mitochondrial Dysfunction in Substance-Induced Neurodegeneration

Investigation of oxidative stress, ATP depletion, and apoptotic cascades in drug-induced neuronal death.

Behavioral Phenotyping for Personalized Addiction Treatment

Development of computational models integrating behavioral assessments to predict optimal treatment selection and dosing.

Astrocyte-Neuron Signaling and Addiction Plasticity

Study of astrocytic contribution to synaptic plasticity, neuroinflammation, and treatment response in substance use disorders.

Nicotinic Acetylcholine Receptor Subtypes in Addiction

Investigation of alpha7 and alpha4-beta2 nAChR variants'' roles in dependence severity and cognitive impairment.

Heroin-Induced Immunosuppression and HIV Vulnerability

Characterization of opioid-direct immunomodulation effects on CD4 count decline and opportunistic infection risk.

Stimulant-Induced Cardiomyopathy Long-Term Outcomes

Longitudinal cardiac imaging and functional assessment of cocaine and methamphetamine users with addiction-related heart failure.

Methamphetamine and Dental Caries Mechanism

Investigation of meth mouth pathogenesis including xerostomia, acidic environment, and poor hygiene in substance users.

Gender-Affirming Care and Substance Use Outcomes

Study of how gender-affirming medical and psychological support affects addiction treatment engagement in transgender populations.

Social Network Analysis and Recovery Pathways

Application of network science methods to identify peer influence dynamics and optimal support structures for sustained recovery.

Ecological Momentary Assessment of Craving Patterns

Real-time smartphone-based monitoring of craving trajectories, triggers, and contextual factors in naturalistic environments.

Quantitative EEG and Event-Related Potentials in Addiction

Use of qEEG spectral analysis and ERP components to identify neurophysiological markers of cue reactivity and impulse control.

Fetal Programming of Addiction Vulnerability

Study of maternal stress, nutrition, and substance exposure''s lasting effects on hypothalamic-pituitary-adrenal axis and reward sensitivity.

Naloxone Auto-Injector Distribution and Implementation

Evaluation of community-based naloxone access programs'' effectiveness in reducing opioid overdose fatality rates.

Fentanyl Analog Detection and Forensic Chemistry

Development of rapid screening methods and toxicological assays for emerging synthetic opioid derivatives in substance analysis.

Racial Disparities in Addiction Treatment Access

Investigation of systemic barriers, implicit bias, and culturally-tailored intervention effectiveness in minority substance users.

Cannabis Potency and Psychosis Risk Gradient

Dose-response analysis of THC concentration in cannabis products and development of psychotic symptoms in vulnerable individuals.

Prescription Stimulant Misuse in ADHD Populations

Study of medication diversion patterns, non-medical use, and addiction development in individuals with ADHD.

Antigen-Based Cocaine Vaccine Development

Immunological approaches using catalytic antibodies and hapten immunization to block cocaine''s central nervous system effects.

Real-World Evidence and Comparative Effectiveness Research

Analysis of electronic health records and claims data to assess long-term treatment outcomes across diverse addiction populations.

Substance Use in Seasonal Affective Disorder

Investigation of seasonal patterns in addiction relapse, light therapy interactions, and mood regulation in northern climates.

Contingent Negative Variation and Decision-Making Deficits

ERP assessment of preparatory brain activity and executive dysfunction underlying poor treatment adherence.

Recovery Housing Models and Relapse Prevention

Randomized trials comparing structured sober living environments, peer management, and supported housing on recovery outcomes.

Dopamine D3 Receptor Selectivity in Treatment

Development of selective D3 receptor antagonists and agonists to target addiction-specific reward pathways without motor side effects.

Kappa Opioid Receptor Antagonism for Dysphoria

Exploration of kappa receptor blockade to reduce negative affect and anhedonia driving relapse in addiction disorders.

Endocannabinoid System Rebalancing Strategies

Research on restoring endogenous cannabinoid signaling to normalize motivational processing and reduce craving intensity.

Neuroinflammatory Cytokine Modulation in Recovery

Investigation of pro-inflammatory cytokine reduction and microglial activation suppression to enhance neurobiological healing.

Proteasomal Protein Degradation and Addiction Memory

Study of ubiquitin-proteasome system function in reconsolidation blockade and extinction learning enhancement.

Neuropeptide Y Signaling in Stress Resilience

Examination of NPY augmentation strategies to enhance stress buffering and reduce negative reinforcement driven relapse.

Histone Deacetylase Inhibitors and Gene Expression

Research on HDAC modulators to reverse addiction-related epigenetic silencing of protective genes.

Astrocyte-Neuron Communication in Addiction Recovery

Investigation of glial cell dysfunction and restoration of astrocyte-mediated neurotrophic support in treatment.

Synaptic Spine Density Remodeling and Abstinence

Study of dendritic spine plasticity changes during recovery and neurobiological mechanisms enabling circuit reorganization.

Oxytocin Receptor Agonism in Social Motivation

Research on oxytocin augmentation to enhance social reward processing and reduce isolation-driven substance use.

Lactate Signaling in Brain Metabolism and Addiction

Investigation of astrocyte-derived lactate effects on neuronal energy metabolism and addiction-related cognitive dysfunction.

Precision Medicine Pharmacogenomics in Addiction Treatment

Development of personalized medication selection algorithms based on individual genetic and metabolic profiles.

Real-Time Biofeedback Neurotherapy for Cue Reactivity

Application of fMRI or EEG biofeedback to enable self-regulation of brain circuits responding to addiction cues.

Wearable Biosensor Prediction of Relapse Risk

Development of physiological sensor systems detecting heart rate variability, cortisol, and movement patterns predicting imminent relapse.

Vagus Nerve Stimulation and Extinction Learning

Research on non-invasive vagal stimulation combined with exposure therapy to enhance extinction memory consolidation.

Cannabidiol Anxiolytic Mechanisms Independent of THC

Investigation of cannabidiol''s serotonergic and TRPV1-mediated anxiolytic effects as adjunct addiction treatment.

Genetic Variants in Addiction Treatment Response Prediction

Identification of single nucleotide polymorphisms predicting individual treatment response to MAT and behavioral interventions.

Cortisol Dysregulation and HPA Axis Recovery Trajectory

Longitudinal assessment of hypothalamic-pituitary-adrenal axis normalization during treatment and its association with outcomes.

Gut Dysbiosis Manipulation Through Probiotic Intervention

Study of specific psychobiotic strains restoring microbiota composition and reducing behavioral addiction severity.

Cognitive Remediation for Addiction-Related Impairment

Development and validation of targeted interventions improving executive function and decision-making in persons with addiction.

Brain-Derived Neurotrophic Factor Augmentation Strategies

Investigation of BDNF enhancement through exercise, environmental enrichment, and pharmacological approaches for neuroplasticity.

Mindfulness-Based Relapse Prevention Neurobiological Mechanisms

Neuroimaging study of anterior insula and default mode network changes underlying mindfulness treatment efficacy.

Exercise-Induced Endorphin Release and Craving Reduction

Research on physical activity modulation of endogenous opioid tone and dopaminergic reward to substitute drug effects.

Sleep Architecture Disruption and Relapse Vulnerability

Investigation of REM and non-REM sleep stage abnormalities and their intervention through sleep-focused treatment.

Interoceptive Awareness Training in Craving Management

Development of interventions enhancing bodily sensation recognition to differentiate craving-related physiological cues.

Monetary Incentive Delay Task Optimization for Anhedonia

Refinement of reward responsiveness assessment and personalized intervention targeting blunted reward sensitivity.

Serotonin Transporter Availability and Mood Disorders

PET imaging study of SERT density changes across addiction and co-occurring depression trajectories during treatment.

Pharmacokinetic-Pharmacodynamic Modeling for Dosing Optimization

Development of population PK-PD models to individualize MAT dosing based on pharmacogenetic and clinical variables.

Implicit Cognition Modification Through Computer-Based Training

Research on attention bias modification and approach-avoidance retraining to reduce automatic cue-seeking behaviors.

Housing First Models and Addiction Treatment Engagement

Evaluation of permanent supportive housing impact on treatment retention and recovery outcomes in severe addiction.

Employment Interventions and Recovery Capital Enhancement

Investigation of vocational training and supported employment effectiveness in building protective recovery resources.

Cultural Adaptation of Evidence-Based Addiction Treatments

Development and testing of culturally tailored treatment modifications for diverse ethnic and religious populations.

Motivational Interviewing Fidelity and Implementation Science

Research on trainer competency, supervision models, and organizational factors affecting MI implementation effectiveness.

Dialectical Behavior Therapy Adaptation for Substance Use

Investigation of DBT module effectiveness in treating addiction with severe emotion dysregulation and self-harm.

Mutual Support Recovery Organizations Network Analysis

Social network research examining peer influence mechanisms in 12-step and SMART Recovery group effectiveness.

Addiction and Chronic Disease Comorbidity Prevention

Integrated care models targeting simultaneous management of addiction, cardiovascular disease, and metabolic disorders.

Hepatitis C Screening and Treatment Linkage in Addiction

Research on barriers and facilitators to HCV identification and direct-acting antiviral therapy uptake during addiction care.

HIV Prevention and Treatment in Persons with Addiction

Investigation of pre-exposure prophylaxis uptake, antiretroviral adherence, and undetectable equals untransmittable outcomes.

Tuberculosis Comorbidity and Drug-Drug Interaction Management

Study of medication interactions between addiction treatments and tuberculosis agents, and optimized co-management protocols.

Reproductive Health and Addiction Medicine Integration

Research on contraception counseling, pregnancy outcomes, and postpartum recovery support in persons with addiction.

Pediatric Opioid Exposure and Developmental Outcomes

Longitudinal study of neurodevelopmental, behavioral, and socio-emotional outcomes in children exposed to in utero substances.

Medication Timing and Circadian-Aligned Drug Administration

Investigation of chronotherapy principles optimizing MAT dosing based on circadian biology to enhance efficacy.

Synaptopathology Biomarkers Through Cerebrospinal Fluid Analysis

Research on synaptosomal proteins and synaptic vesicle markers in CSF as objective addiction severity and recovery indicators.

Environmental Enrichment and Recovery Housing Optimization

Study of physical environment design, nature exposure, and social layout effects on neural recovery and treatment outcomes.

Meaning-Making and Existential Psychotherapy in Addiction

Investigation of narrative therapy and existential approaches addressing identity reconstruction during recovery.

Estrogen Signaling and Sex-Specific Addiction Vulnerability

Investigation of how estrogen receptor dynamics modulate dopaminergic responses and relapse risk across the menstrual cycle, menopause, and hormone replacement therapy in substance use disorder populations.

Proteomic and Metabolomic Signatures in Addiction Recovery

Discovery of peripheral protein and metabolite biomarkers that predict sustained abstinence trajectories and identify individuals at risk for early relapse in multisubstance use disorders.

Addiction Medicine Workforce Training and Competency Standards

Research on optimal training curricula, competency assessment, and dissemination of evidence-based addiction medicine practices.

Inflammation-Mediated Cognitive Impairment in Stimulant Use Disorder

Examination of neuroinflammatory pathways, particularly microglial activation and cytokine signaling, as mechanisms underlying executive dysfunction and decision-making deficits in methamphetamine and cocaine addiction.

Predictive Pharmacogenomics for Personalized Addiction Pharmacotherapy

Development of multi-gene pharmacogenomic panels that integrate CYP450, OPRM1, and COMT variants to predict individual medication metabolism, treatment response, and adverse event risk in medication-assisted treatment protocols.